Zika virus: Canadian-U.S. vaccine could be ready by year's end
Human tests could start as early as September, says University of Laval's Gary Kobinger
A vaccine for the Zika virus in development by U.S. and Canadian scientists could be available for emergency use before the end of the year, possibly making it the first, one of the lead scientists said on Thursday.
- Canadian-U.S. vaccine could be ready by year's end
- Zika virus outbreak 'spreading explosively': WHO
- 6 things to know about the Zika virus
- Canadian Blood Services to defer donations from travellers to Zika areas
- Airlines to refund or let passengers change flights over Zika concerns
The consortium working on the vaccine includes University of Pennsylvania, led by scientist David Weiner, University of Laval, led by Gary Kobinger, Inovio Pharmaceuticals Inc. and South Korea's GeneOne Life Science, Kobinger told Reuters in an interview.
He hopes to start trials by September to test its safety on humans, pending regulator approval. A month later it could be ready for emergency use.